Kennedy objects to delay in US safety regulations
This article was originally published in Clinica
US Democrat Senator Edward Kennedy has expressed his frustration that regulations to implement the Patient Safety and Quality Improvement Act have still not been introduced.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.